Skip to main content
Publications
Hauber B, Paulsen R, Krasa HB, Vradenburg G, Comer M, Callahan LF, Winfield J, Potashman M, Hartry A, Lee D, Wilson H, Hoffman DL, Weiberg D, Kremer IN, Taylor GA, Taylor JM, Lappin D, Martin AD, Frangiosa T, Biggar V, Slota C, Romano (DeMuro) C , DiBenedetti D . Assessing what matters to people affected by Alzheimer's disease: a quantitative analysis . Neurol Ther. 2023 Apr;12(2):505-27. doi: 10.1007/s40120-023-00445-0
DiBenedetti D , Menne H, Paulsen R, Krasa HB, Vradenburg G, Comer M, Callahan LF, Winfield J, Potashman M, Heithoff K, Hartry A, Oberdhan D, Wilson H, Hoffman DL, Weinberg D, Kremer IN, Taylor GA, Taylor JM, Lappin D, Martin AD, Hauber B, Romano (DeMuro) C . Technical review of clinical outcomes assessments across the continuum of Alzheimer's disease . Neurol Ther. 2023 Apr;12(2):571-95. doi: 10.1007/s40120-023-00443-2
Goldberg X, Castano-Vinyals G, Espinosa A, Carreras A, Liutsko L, Sicuri E, Foraster M , O'Callaghan-Gordo C, Dadvand P, Moncunill G, Dobano C, Cortes B, Pleguezuelos V, Straif K, Garcia-Aymerich J, de Cid R, Cardis E, Kogevinas M. Mental health and COVID-19 in a general population cohort in Spain (COVIVAT Study) . Soc Psychiatry Psychiatr Epidemiol. 2022 Dec;57(12):2457-68. doi: 10.1007/s00127-022-02303-0
Forns J , Dudukina E, Hagg D, Szentkuti P, Gembert K, Plana E , Gilsenan A , Horvath-Puho E, Ehrenstein V, Reutfors J, Rebordosa C . Risk of major cardiovascular and cerebrovascular events in users of lisdexamfetamine and other medications for attention-deficit/hyperactivity disorder in Denmark and Sweden: a population-based cohort study . Neurol Ther. 2022 Dec 1;11(4):1659-76. doi: 10.1007/s40120-022-00396-y